EBOS announces acquisition of ZEST

EBOS Group Limited today announced the acquisition of ZEST as part of the Company’s expanding presence in the delivery and administration of specialty pharmaceutical products.

ZEST is a leading healthcare communications business with extensive experience in medical education, digital solutions, patient services, strategic consultancy, health service development, research and evaluation.

EBOS Group Chief Executive Officer Patrick Davies said the acquisition would add valuable new specialised healthcare resources to complement the range of existing distribution and market access services in the Group.

Pharmaceutical companies are increasingly seeking partners with deep local sector knowledge and the requisite skills to create customised scalable solutions for the delivery and administration of specialty products. 

“ZEST has been a pioneer and leader in providing a range of specialised services to pharmaceutical companies for ten years now and the combined strength of EBOS and ZEST will enable full end-to-end service provision for selected products - from storage and distribution to program creation and management, as well as community-based access and administration,” Mr Davies said.

He said there are many new products that require innovative delivery models and EBOS is adapting its business to participate in these emerging opportunities.

ZEST Managing Director Fiona Grigg said teaming with EBOS provides an excellent platform to expand the range of services even further. 

“This is an exciting step forward for the team at ZEST and I'm looking forward to the opportunities we can now pursue as part of the broader EBOS Group,” Ms Grigg said.